Loading…
← CockpitCompetitor Analysis › 4118.T Kaneka CorporationOpen in the cockpit ↗

Kaneka Corporation4118.TCompetitor analysis, valuation and peers

Japan · JPY·Materials›Chemicals: Specialty

Diversified Japanese chemicals maker spanning plastics, functional polymers, foods (margarine, CoQ10) and biotech.

≈ A diversified Japanese chemicals conglomerate like a smaller BASFMomentum strong 75
Mkt cap
$2.35B
US dollars, full cap
Free float
62%
of shares outstanding
$/day
$11.2M
20-day average traded
Fwd P/E
12.0×
forward earnings
ROIC−WACC
-1.8 pp
WACC 6.3%
Hurdle
-4 pp
Req g minus delivered
Next earnings
83 days
9 Feb 2027
Close · JPY¥6,259
1D-1.2%
1W+1.1%
1M+1.4%
3M-1.4%
6M+16.9%
YTD+42.4%
1Y+46.7%
ATR %2.4%
52w lowhigh5.7% off high

What Kaneka does

Diversified Japanese chemicals maker spanning plastics, functional polymers, foods (margarine, CoQ10) and biotech.

Spreads across many product lines that follow different cycles, so no single one sets results: polymers for building and electronics, foods, medical devices and fermentation-made ingredients. Green Planet, a biodegradable plastic produced by bacteria, is the newer bet and depends on building plant capacity to scale it up.

In one line: A diversified Japanese chemicals conglomerate like a smaller BASF.

Products and services

  • PVC/functional plastics
  • Foods (margarine, CoQ10 supplements)
  • Biotech/pharma intermediates
  • Solar cells/electronic materials

Customers

  • Plastics processors/manufacturers
  • Food/supplement manufacturers
  • Pharma/biotech customers

Where it sits in the supply chain

  • Materials
  • Diversified chemicals
  • Plastics, functional polymers, food…

What could go right

  • Biodegradable plastics demand growth
  • Nutraceutical/supplement market growth

What could go wrong

  • Diversified conglomerate discount
  • Petrochemical feedstock cost volatility

Moat: narrow (IP / patents, process know-how). Broad specialty-chemical and biotech IP portfolio, though diversified across many sub-scale businesses.

Headquarters: Osaka, Japan · Founded: 1949 · Employees: 11,762

Named competitors

Kaneka at a glance

Size Kaneka (4118.T) is a Japan Materials company (Chemicals: Specialty) with a market value of $2.35B, the 444th largest of 1,370 Japan companies the cockpit tracks. Shares closed at ¥6,259 on 18 Nov 2026.

Performance Over six months the shares gained 16.9%, against -18.6% for the median peer and -1.4% for the Japan market (cap-weighted) — 2nd highest of 21 in its peer set.

Growth Revenue grew 6.5% over the last twelve months (peer median +8.3%); the operating margin is 5.4% (peer median 8.6%).

Valuation It trades at 12.0× forward earnings against a peer median of 17.1× (4th cheapest of 17).

Price implies For today's price to make sense, revenue must grow about 3% a year for seven years (Req g). Recent delivered growth is +7%, so the hurdle is -4 pp: the price already allows for a slowdown.

Capital Return on invested capital runs 1.8 points below its cost of capital (6.3% WACC).

Next results Next results expected around 9 Feb 2027 (exchange calendar; dates can move).

Relative performance

8010012021 May 202621 Aug 202618 Nov 20264118.T 118Peer median 82
Six months, rebased to 100: Kaneka against the median of its 20 peers (local-currency closes).

Kaneka financials

Reported figures in JPY; fiscal year ends 2026-03-31. TTM = trailing twelve months.
TTMFY2025FY2024FY2023FY2022
Revenue¥861B¥812B¥807B¥762B¥756B
Revenue growth—+1%+6%+1%—
Gross profit¥248B¥215B¥216B¥195B¥190B
EBITDA¥95.3B¥79.6B¥83.7B¥72.9B¥74.0B
Net income¥34.6B¥31.0B¥25.3B¥23.2B¥23.0B
Free cash flown/a¥1.35B-¥9.93B¥596M-¥10.9B
Capital expendituren/a¥53.4B¥56.0B¥65.3B¥42.0B
Total debt¥224B¥231B¥223B¥195B¥176B

Quarterly statements and history in the cockpit →

Kaneka competitor charts

The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.

Performance: 6-month against 1-month return

-40%-20%0%+20%-20%-10%0%301286600623011790DEEPAKNTR6883634202600339KEMIRASDF300821ROG300073688778PIINDKWR0025686005000021454118.T6-month return →1-month return →
Up and to the right = strong over both horizons. Kaneka is the large dot.

Fundamentals: revenue growth against valuation

0%+50%+100%20×40×60×301286600623DEEPAKNTR6883634202600339KEMIRASDFROG300073688778605020PIIND0025684118.TRevenue growth (TTM) →Forward P/E →
Further right = faster growth; higher = more expensive. The dashed lines are the peer medians. Kaneka is the large dot.

Capital: growth delivered against growth the price implies

-10%0%+10%+20%+30%0%20%3012866006236883634202KEMIRA300821ROG688778KWR0025686005004118.TGrowth delivered (Del g) →Growth the price implies (Req g, 7 yrs) →
Above the diagonal = the price needs more growth than the company has been delivering; below = the price already allows for a slowdown. Kaneka is the large dot.

Kaneka competitors and peer comparison

Head to head with its named competitors (4118.T vs BAS.DE vs 4188.T vs DSFIR.AS)
CompanyMarket cap6M returnRevenue growthOp. marginForward P/EReq g
Kaneka 4118.T$2.35B+17%+6%5%12.0×3.3%
Basf BAS.DE$50.1B0%-4%7%15.8×5.7%
Mitsubishi Chemical 4188.T$8.75B+3%-1%8%9.0×-1.0%
DSM-Firmenich DSFIR.AS$27.5B+47%-45%8%28.6×23.7%

How Kaneka compares with its peers

Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.

Kaneka against its 20 peers (data as of 18 Nov 2026)
Measure4118.TPeer medianRank in peer set
1-month return+1.4%-8.5%2nd highest of 21
6-month return+16.9%-18.6%2nd highest of 21
Distance from 52-week high-5.7%-40.7%highest of 21
Revenue growth (TTM)+6.5%+8.3%6th lowest of 21
Operating margin5.4%8.6%7th lowest of 20
Forward P/E12.0×17.1×4th cheapest of 17
Growth the price implies (Req g, 7 yrs)3.3%13.6%2nd least demanding of 12
Growth delivered (Del g)+7.0%+8.1%5th lowest of 12
Hurdle (Req g minus delivered)-3.8 pp+9.2 pp4th least demanding of 12
ROIC minus cost of capital-1.8 pp-1.5 pp10th highest of 19
EV / EBITDA5.9×13.0×cheapest of 7
Net debt / EBITDA1.8×1.2×3rd most indebted of 7

Peer table

Peer set: Industry: the same industry and sector in any market, nearest in size
CompanyMarketMarket cap6M returnRevenue growthOp. marginForward P/EReq gDelivered g
Kaneka 4118.TJapan$2.35B+17%+6%5%12.0×3.3%+7.0%
Sichuan Qiaoyuan Gas 301286.SZChina$2.33B-37%+8%26%59.2×27.6%+8.0%
Shanghai Huayi 600623.SSChina$2.31B-16%+5%n/a13.6×-11.3%+10.3%
SKC 011790.KSSouth Korea$2.42B-52%+24%-9%n/an/an/a
Deepak Nitrite DEEPAKNTR.NSIndia$2.28B-13%+25%14%16.8×n/an/a
Bloomage Biotechnology 688363.SSChina$2.27B-21%-22%5%52.0×19.0%+9.8%
Daicel 4202.TJapan$2.45B+31%+7%8%10.9×4.2%+8.1%
China Petroleum Engineering 600339.SSChina$2.46B-22%+8%1%24.5×n/an/a
Kemira KEMIRA.HEFinland$2.47B-12%-3%8%15.8×3.9%+2.6%
K+s SDF.DEGermany$2.51B-13%+7%28%10.5×n/an/a
Shandong Dongyue Silicone Material 300821.SZChina$2.19B-23%+13%13%n/a18.8%+8.6%
Qingdao Gon Technology 2768.HKHong Kong$2.52B-17%+20%7%9.7×n/an/a
Rogers ROGUnited States$2.18B-8%+7%10%26.3×10.8%+0.2%
Beijing Easpring Material Technology 300073.SZChina$2.56B-45%+116%5%17.8×n/an/a
XTC New Energy Materials (Xiamen) 688778.SSChina$2.59B-51%+78%4%16.5×13.7%+20.0%
Zhejiang Yonghe Refrigerant 605020.SSChina$2.12B-13%+25%18%13.2×n/an/a
PI Industries PIIND.NSIndia$2.63B-48%-15%13%31.6×n/an/a
Quaker Houghton KWRUnited States$2.66B+10%+9%9%17.4×17.1%+5.9%
Shanghai Bairun Investment 002568.SZChina$2.67B-7%+8%28%23.0×13.6%+8.8%
Sinochem International 600500.SSChina$2.06B-31%-5%-1%n/a11.0%-2.7%
Tinergy Chemical 002145.SZChina$2.06B-20%+17%9%n/an/an/a

Questions

Who are Kaneka's main competitors?
Named competitors: BASF (BAS.DE), Mitsubishi Chemical Group (4188.T), DSM-Firmenich (DSFIR.AS). The cockpit's measured peer set (industry) also includes Sichuan Qiaoyuan Gas (301286.SZ), Shanghai Huayi (600623.SS), SKC (011790.KS), Deepak Nitrite (DEEPAKNTR.NS), Bloomage Biotechnology (688363.SS), Daicel (4202.T).
Is Kaneka expensive compared with its peers?
On forward p/e it trades at 12.0× against a peer median of 17.1×, 4th cheapest of 17 in its peer set. For today's price to make sense, revenue must grow about 3% a year for seven years (Req g). Recent delivered growth is +7%, so the hurdle is -4 pp: the price already allows for a slowdown.
How has Kaneka stock performed?
Over six months to 18 Nov 2026 the shares returned +16.9% against -18.6% for the median peer; over one year +46.7%.

How these numbers are made. Returns are close-to-close in local currency. Revenue growth and margins are trailing twelve months. Req g is the revenue growth that today's enterprise value requires for seven years at the company's own cost of capital; Delivered g is what it actually grew; the gap is the hurdle (honest precision about ±8 points, so read the ranking more than the decimal). No fair values, price targets or analyst ratings are shown, by design. Method and validation.